Chong Kun Dang saw the highest growth of 0.99% in patent filings and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of Chong Kun Dang’s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Chong Kun Dang has been focused on protecting inventions in South Korea(KR) with three publications in Q2 2024

The South Korea(KR) Patent Office dominates the patent filings and grants with nearly 67% filings and 100% grants. The South Korea(KR), and European Patent Office(EPO) patent Office are among the top ten patent offices where Chong Kun Dang is filings its patents. Among the top granted patent authorities, Chong Kun Dang has 100% of its grants in South Korea(KR).

Eli Lilly and Co could be the strongest competitor for Chong Kun Dang

Animal feed related patents lead Chong Kun Dang portfolio followed by pet care, and kidney disease (nephropathy)

Chong Kun Dang has highest number of patents in animal feed followed by pet care, kidney disease (nephropathy).

For comprehensive analysis of Chong Kun Dang's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.